The following table provides an overview of the latest patents of Agios Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3307271Sep 13, 2023Methods Of Using Pyruvate Kinase Activators2
EP3713919Aug 2, 2023Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide2